companydata.dkGXP PHARMAID ApS: Financial statements 2020
CVR: 29615861
GXP PHARMAID ApS (CVR 29615861) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 2,798,982 and a net result of DKK 960,283 compared with DKK -168,984 the year before. That is an increase of 267.1% compared with the year before. Equity amounted to DKK 1,695,248. The solvency ratio was 56.8%. The company had 3 employees in the financial year.
- Gross Profit
- 2,798,982 kr.
- Profit/Loss
- 960,283 kr.
- Equity
- 1,695,248 kr.
- Total Assets
- 2,983,924 kr.
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 2.8 mio. | 960 t. | 1.7 mio. | 3 |
| 2019 | - | 763 t. | -169 t. | 735 t. | 1 |
| 2018 | - | 1.1 mio. | 217 t. | 904 t. | 1 |
| 2017 | - | 1.4 mio. | 142 t. | 687 t. | 1 |
| 2016 | - | 1.6 mio. | 97 t. | 544 t. | - |
Events in 2020
GXP PHARMAID ApS has published its annual report for 2019. Gross profit came to DKK 762,547, and the net result was DKK -168,984.
About GXP PHARMAID ApS
GXP PHARMAID ApS is a Danish company of the type Anpartsselskab based in Brønshøj, founded in 2006. The company is registered under the industry Anden teknisk rådgivning. The management consists of Nusret Asanovski. The company is owned by MAC ANDORBY ApS. The company has 2 employees. In 2024, the company reported a gross profit of DKK 1,340,825 and a net result of DKK 216,532 compared with DKK 513,163 the year before. Equity amounted to DKK 1,096,211.